Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up

The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group·2016·Diabetes Care
DOI 10.2337/dc15-1990

Cited by (712)

Items 101–200 of 712

  1. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study
    Timothy J. Roberts, Andrew Burns, Richard J. MacIsaac, Andrew I. MacIsaac, David Prior, André La Gerche · 2018 · Cardiovascular Diabetology
  2. The legacy effect in diabetes: are there long-term benefits?
    Rachel Folz, Neda Laiteerapong · 2021 · Diabetologia
  3. Excess Cardiovascular Risk in Type 1 Diabetes Mellitus
    John R. Petrie, Naveed A. Sattar · 2019 · Circulation
  4. Safety and efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 1 diabetes: a systematic review and meta-analysis
    El Masri, Dana, Ghosh, Samiran, Jaber, Linda A. · 2018 · Diabetes Research and Clinical Practice
  5. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study
    Barbara H. Braffett, Samuel E. Dagogo-Jack, Ionut Bebu, William I. Sivitz, Mary E. Larkin, Orville Kolterman, John M. Lachin · 2019 · Diabetes Care
  6. The double burden: type 1 diabetes and heart failure—a comprehensive review
    María Teresa Julián, Alejandra Pérez-Montes de, Josep Julve, Núria Alonso · 2024 · Cardiovascular Diabetology
  7. β Cell Replacement Therapy
    Christian Schuetz, Takayuki Anazawa, Sarah E. Cross, Letícia Labriola, Raphael P. H. Meier, Robert R. Redfield, Hanne Scholz, Peter G. Stock, Nathan W. Zammit · 2017 · Transplantation
  8. What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?
    William H. Herman, Barbara H. Braffett, Shihchen Kuo, Joyce M. Lee, Michael Brändle, Alan M. Jacobson, Lisa A. Prosser, John M. Lachin · 2018 · Journal of Diabetes and its Complications
  9. Real‐world outcomes of insulin pump compared to injection therapy in a population‐based sample of children with type 1 diabetes
    Marie‐Anne Burckhardt, Grant J. Smith, Matthew N. Cooper, Timothy William Jones, Elizabeth Ann Davis · 2018 · Pediatric Diabetes
  10. Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?
    Snaith, Jennifer R., Holmes-Walker, Deborah J., Greenfield, Jerry R. · 2020 · Trends in Endocrinology & Metabolism
  11. Diabetes Stigma and Clinical Outcomes in Adolescents and Young Adults: The SEARCH for Diabetes in Youth Study
    Eitel, Kelsey B., Roberts, Alissa J., D’Agostino, Ralph, Barrett, Catherine E., Bell, Ronny A., Bellatorre, Anna, Cristello, Angelica, Dabelea, Dana, Dolan, Lawrence M., Jensen, Elizabeth T. et al. · 2023 · Diabetes Care
  12. Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes
    Rozana Ramli, Monika Reddy, Nick S. Oliver · 2019 · Drugs
  13. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring
    Michelle Diane Lundholm, Mary Ann Emanuele, Alina Ashraf, Sarah Nadeem · 2020 · Journal of Diabetes and its Complications
  14. The human aortic endothelium undergoes dose-dependent DNA methylation in response to transient hyperglycemia
    Mark E. Pepin, Concetta Schiano, Marco Miceli, Giuditta Benincasa, Gelsomina Mansueto, Vincenzo Grimaldi, Andrea Soricelli, Adam R. Wende, Claudio Napoli A · 2021 · Experimental Cell Research
  15. Effect of duration and burden of microvascular complications on mortality rate in type 1 diabetes: an observational clinical cohort study
    Bjerg, Lasse, Hulman, Adam, Carstensen, Bendix, Charles, Morten, Witte, Daniel R., Jørgensen, Marit E. · 2019 · Diabetologia
  16. Preventing diabetes complications
    Sophie Templer, Sarah Abdo, Tang Wong · 2024 · Internal Medicine Journal
  17. Similar glycaemic control with less nocturnal hypoglycaemia in a 38-week trial comparing the IDegAsp co-formulation with insulin glargine U100 and insulin aspart in basal insulin-treated subjects with type 2 diabetes mellitus
    Athena Philis‐Tsimikas, K. Astamirova, Yashdeep Gupta, Amina Z. Haggag, Daoud Roula, Britta Anker Bak, Edmond G. Fita, A.M. Nielsen, Tevfik Demir · 2018 · Diabetes Research and Clinical Practice
  18. The Association of Severe Diabetic Retinopathy With Cardiovascular Outcomes in Long-standing Type 1 Diabetes: A Longitudinal Follow-up
    Draženka Pongrac Barlovič, Valma Harjutsalo, Daniel Gordin, Milla Kallio, Carol M. Forsblom, George Liang King, Per‐Henrik Groop · 2018 · Diabetes Care
  19. Role of Oral Antioxidant Supplementation in the Current Management of Diabetic Retinopathy
    Enrique A. Alfonso-Muñoz, Raquel Burggraaf-Sánchez de las Matas, J. Mataix, Julio César Molina Martín, Carmen Desco · 2021 · International Journal of Molecular Sciences
  20. Metabolic memory: Evolving concepts
    Anoop Misra, Zachary T. Bloomgarden · 2017 · Journal of Diabetes
  21. Metformin in adults with type 1 diabetes: D esign and methods of REducing with MetfOrmin V ascular A dverse L esions ( REMOVAL ): A n international multicentre trial
    John R. Petrie, Nish Chaturvedi, Ian Ford, IRENE M. HRAMIAK, Alun David Hughes, Alicia Josephine Jenkins, Barbara E.K. Klein, Ron Klein, Teik Chye Ooi, Peter R Rossing et al. · 2016 · Diabetes Obesity and Metabolism
  22. The effects of family functioning and resilience on self‐management and glycaemic control among youth with type 1 diabetes
    Dan Luo, Jingjing Xu, Xue Cai, Min Zhu, Hong Wang, Dan Yan, Mingzi Li · 2019 · Journal of Clinical Nursing
  23. Effectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes
    Snell-Bergeon, Janet K., Kaur, Gurleen, Renner, Drew, Akturk, Halis K., Beatson, Christie, Garg, Satish K. · 2025 · Diabetes Technology & Therapeutics
  24. Insulin and Its Cardiovascular Effects: What Is the Current Evidence?
    Sahana Pai Dongerkery, Pamela Rose Schroeder, Mansur E. Shomali · 2017 · Current Diabetes Reports
  25. Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe
    Andrej Janež, Tadej Battelino, Tomasz Klupa, Győző Kocsis, M Kuricova, Nebojsa M. Lalic, Anca Pantea Stoian, Martin Prázný, Dario Rahelić, Jan Šoupal et al. · 2021 · Diabetes Therapy
  26. Trained immunity and diabetic vascular disease
    Kathrin Thiem, Rinke Stienstra, Niels Peter Riksen, Samuel T. Keating · 2019 · Clinical Science
  27. Clinical application guidelines for blood glucose monitoring in China (2022 edition)
    Y.-Z. Bao, Da-Long Zhu · 2022 · Diabetes/Metabolism Research Reviews
  28. Impact of insulin pump on quality of life of diabetic patients
    Haider Ghazanfar, Syed Wajih Rizvi, Aliya Khurram, Fizza Orooj, Iman Qaiser · 2016 · Indian Journal of Endocrinology and Metabolism
  29. Diabetes Care in the School Setting: A Statement of the American Diabetes Association
    Fran R. Cogen, Henry Rodriguez, Christine A. March, Cynthia E. Muñoz, Jacqueline McManemin, Margaret Pellizzari, Janet Rodriguez, Leah Wyckoff, Alan L. Yatvin, Torie Atkinson et al. · 2024 · Diabetes Care
  30. RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India
    Ping Rao, B. M. Makkar, Ajay Kumar, Ashok Kumar Das, Awadhesh Kumar Singh, Ambrish Mithal, Anil Bhansali, Anoop Misra, Anuj Maheshwari, Arvind Gupta et al. · 2018 · International Journal of Diabetes in Developing Countries
  31. Socioeconomic Inequality in Metabolic Control Among Children With Type 1 Diabetes: A Nationwide Longitudinal Study of 4,079 Danish Children
    Nick Fabrin Nielsen, Amanda Gaulke, Tine Louise Mundbjerg Eriksen, Jannet Svensson, Niels Skipper · 2019 · Diabetes Care
  32. Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study
    Sebastian Seget, Przemysława A. Jarosz-Chobot, Agnieszka Ochab, Joanna Polańska, Ewa Rusak, Paulina Witoszek, Agata P Chobot · 2022 · Frontiers in Endocrinology
  33. Hemoglobin glycation index and cardiovascular outcomes in patients with diabetes and coronary artery disease: insights from a large cohort study
    Zhangyu Lin, Jining He, Sheng Yuan, Chenxi Song, Xiaohui Bian, Min Yang, Kefei Dou · 2024 · Nutrition and Diabetes
  34. O-GlcNAcylation-mediated endothelial metabolic memory contributes to cardiac damage via small extracellular vesicles
    Mingge Ding, Rui Shi, Yanyan Du, Pan Chang, Tian Gao, Dema De, Yunan Chen, Man Li, Jun Li, Ké Li et al. · 2025 · Cell Metabolism
  35. Adjunctive therapy for glucose control in patients with type 1 diabetes
    Kira Harris, Cassie L. Boland, Lisa T. Meade, Dawn M. Battise · 2018 · Diabetes Metabolic Syndrome and Obesity
  36. One drop | Mobile on iPhone and apple watch: an evaluation of hbA1c improvement associated with tracking self-care
    Osborn, Chandra Y, van Ginkel, Joost R, Marrero, David G, Rodbard, David, Huddleston, Brian, Dachis, Jeff · 2017 · JMIR mHealth and uHealth
  37. Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes—So Why Is Their Uptake So Low?
    Aaron King, Eden M Miller · 2022 · Clinical Diabetes
  38. Low carbohydrate high fat ketogenic diets on the exercise crossover point and glucose homeostasis
    Timothy David Noakes, Philip Prins, Jeff S. Volek, Dominic P. D’Agostino, Andrew Paul Koutnik · 2023 · Frontiers in Physiology
  39. Key indices of glycaemic variability for application in diabetes clinical practice
    Louis Monnier, Fabrice Bonnet, C Colette, Éric Renard, David R. Owens · 2023 · Diabetes & Metabolism
  40. The early detection of atherosclerosis in type 1 diabetes: why, how and what to do about it
    Alicia Josephine Jenkins, Andrzej S. Januszewski, David Norman O'Neal · 2019 · Cardiovascular Endocrinology & Metabolism
  41. Postprandial Dosing of Bolus Insulin in Patients with type 1 Diabetes: a Cross-sectional Study Using Data From the T1d Exchange Registry
    Anne L. Peters, Michelle Anne Van Name, Brian Larsen Thorsted, Johanne Spanggaard Piltoft, William V. Tamborlane · 2017 · Endocrine Practice
  42. Trained immunity and atherosclerotic cardiovascular disease
    Niels Peter Riksen · 2019 · Current Opinion in Lipidology
  43. Are All Patients With Type 1 Diabetes Destined for Dialysis if They Live Long Enough? Probably Not
    George L. Bakris, Mark E. Molitch · 2018 · Diabetes Care
  44. Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
    Laura M. Jacobsen, Jennifer L. Sherr, Elizabeth G. Considine, Angela Chen, Sarah Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, SELMA A. ALAMARIE et al. · 2023 · Communications Medicine
  45. The importance of dyslipidaemia in the pathogenesis of cardiovascular disease in people with diabetes
    Hanney Gonna, Kausik Kumar Ray · 2019 · Diabetes Obesity and Metabolism
  46. Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D
    Arpita Basu, Ionut Bebu, Alicia Josephine Jenkins, Julie Ann Stoner, Ying Zhang, Richard L. Klein, Maria Fernanda Lopes-Virella, William Timothy Garvey, Matthew Jay Budoff, Petar Alaupovic et al. · 2019 · Journal of Lipid Research
  47. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine
    Nicola Tecce, Maria Masulli, Roberta Lupoli, Giuseppe Della Pepa, Lutgarda Bozzetto, Luisa Palmisano, Angela Albarosa Rivellese, Gabriele Riccardi, Brunella Capaldo · 2020 · Cardiovascular Diabetology
  48. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
    Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Hiroshi Ikegami · 2021 · Scientific Reports
  49. Effects of islet transplantation on microvascular and macrovascular complications in type 1 diabetes
    Laura J. Reid, Faye Baxter, Shareen Forbes · 2021 · Diabetic Medicine
  50. The Imbalance of Mitochondrial Fusion/Fission Drives High-Glucose-Induced Vascular Injury
    Yunsi Zheng, Anqi Luo, Xiaoquan Liu · 2021 · Biomolecules
  51. Diabetic dyslipidaemia
    Subashini Chellappah Thambiah, Leslie C. Lai · 2021 · Practical Laboratory Medicine
  52. Evaluation of a Web-Based Simulation Tool for Self-Management Support in Type 1 Diabetes: A Pilot Study
    Patricio H. Colmegna, Alessandro Bisio, Ryan K. McFadden, CHRISTIAN A. WAKEMAN, Mary Clancy Oliveri, Ralf M. Nass, Marc D. Breton · 2022 · IEEE Journal of Biomedical and Health Informatics
  53. Cost-Effectiveness Analysis of a Hybrid Closed-Loop System Versus Multiple Daily Injections and Capillary Glucose Testing for Adults with Type 1 Diabetes
    Pease, Anthony, Zomer, Ella, Liew, Danny, Earnest, Arul, Soldatos, Georgia, Ademi, Zanfina, Zoungas, Sophia · 2020 · Diabetes Technology & Therapeutics
  54. Glycemic control and cardiovascular outcomes in patients with diabetes and coronary artery disease according to triglyceride-glucose index: a large-scale cohort study
    Zhangyu Lin, Jining He, Sheng Yuan, Chenxi Song, Xiaohui Bian, Min Hee Yang, Kefei Dou · 2024 · Cardiovascular Diabetology
  55. Route to improving Type 1 diabetes mellitus glycaemic outcomes: real‐world evidence taken from the National Diabetes Audit
    Adrian Hugh Heald, Mark A. Livingston, Anthony A. Fryer, Gabriela Moreno, Nagaraj S. Malipatil, R. Gadsby, William Ollier, Mark Lunt, Mike Stedman, R. J. Young · 2017 · Diabetic Medicine
  56. Intensive remote monitoring versus conventional care in type 1 diabetes: A randomized controlled trial
    Laura M. Gandrud, Aylin Altan, Paul Buzinec, Jesse Hemphill, Jayne Chatterton, Tina Kelley, Deneen D. Vojta · 2018 · Pediatric Diabetes
  57. Glucocentric risk factors for macrovascular complications in diabetes: Glucose ‘legacy’ and ‘variability’-what we see, know and try to comprehend
    Louis Monnier, C Colette, Jean-Louis Schlienger, Bernard Bauduceau, David R. Owens · 2019 · Diabetes & Metabolism
  58. Stroke in the patient with diabetes (part 1) – Epidemiology, etiology, therapy and prognosis
    David S.H. Bell, Edison Gonçalves · 2020 · Diabetes Research and Clinical Practice
  59. Contemporary Management of Heart Failure in Patients With Diabetes
    James A. Shaw, Mark Emmanuel Cooper · 2020 · Diabetes Care
  60. The bigger, the better? When multicenter clinical trials and meta-analyses do not work
    Soroush Seifirad, Lance Alquran · 2020 · Current Medical Research and Opinion
  61. Association of the use of diabetes technology with HbA1c and BMI‐SDS in an international cohort of children and adolescents with type 1 diabetes: The SWEET project experience
    Marco Marigliano, Alexander J. Eckert, Pravesh Kumar Guness, Antje Herbst, Carmel E. Smart, Michael Witsch, Claudio Maffeis, SWEET Study Group · 2021 · Pediatric Diabetes
  62. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes
    Yehuda Handelsman · 2019 · Advances in Therapy
  63. Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
    Avital Nahmias, Priska Stahel, Changting Xiao, Gary F. Lewis · 2020 · Frontiers in Cardiovascular Medicine
  64. Type 1 Diabetes
    Laura M. Jacobsen, Desmond Schatz · 2026 · JAMA
  65. Pleiotropic effects of anti-diabetic drugs: A comprehensive review
    Moumita Nath, Kasturi Bhattacharjee, Yashmin Choudhury · 2020 · European Journal of Pharmacology
  66. Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes
    Darja Šmigoc Schweiger, Tadej Battelino, Urh Grošelj · 2021 · International Journal of Molecular Sciences
  67. Quality of care in rural youth with type 1 diabetes: a cross-sectional pilot assessment
    Kyle Stumetz, Joyce P. Yi‐Frazier, Connor Mitrovich, Kathaleen Briggs Early · 2016 · BMJ Open Diabetes Research & Care
  68. The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus
    Christopher J. Duff, Ivonne Solis‐Trapala, Owen John Driskell, David Holland, Helen Wright, Jenna Louise Waldron, Clare Ford, Jonathan Scargill, Martin Tran, Fahmy Hanna et al. · 2018 · Clinical Chemistry and Laboratory Medicine (CCLM)
  69. Adherence to Mediterranean Diet Is Associated With Better Glycemic Control in Children With Type 1 Diabetes: A Cross-Sectional Study
    Jesús Domínguez‐Riscart, Nuria Buero-Fernandez, Ana García-Zarzuela, Celia Morales-Perez, Ana García-Ojanguren, Alfonso Maria Lechuga-Sancho · 2022 · Frontiers in Nutrition
  70. Non‐insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions
    Lorena Alarcon-Casas Wright, Irl B. Hirsch · 2019 · Diabetic Medicine
  71. Estimating Glycemia From HbA1c and CGM: Analysis of Accuracy and Sources of Discrepancy
    Veronica Tozzo, Matthew T. Genco, Shammah O. Omololu, Christopher Mow, Hasmukh R. Patel, Chhaya H. Patel, Samantha N. Ho, Evie Lam, Batoul Abdulsater, Nikita Patel et al. · 2024 · Diabetes Care
  72. Changes of insulin resistance status and development of complications in type 1 diabetes mellitus: Analysis of DCCT/EDIC study
    Yuanjie Mao, Wenjun Zhong · 2022 · Diabetes Research and Clinical Practice
  73. Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability
    Vadim Valer'evich Klimontov, Kamilla R. Mavlianova, Н. Б. Орлов, Julia F. Semenova, Anton Ivanovich Korbut · 2023 · Biomedicines
  74. Cardiovascular complications of type 1 diabetes: update on the renal link
    Trevor John Orchard, Tina Costacou · 2016 · Acta Diabetologica
  75. Islet Transplantation Alone Versus Solitary Pancreas Transplantation: an Outcome-Driven Choice?
    Paola Maffi, Antonio Secchi · 2019 · Current Diabetes Reports
  76. Efficacy of automatic bolus calculator with automatic speech recognition in patients with type 1 diabetes: A randomized cross‐over trial: 具有自动语音识别功能的自动剂量计算器在1型糖尿病患者中的应用:一项随机交叉试验
    Foltynski, Piotr, Ladyzynski, Piotr, Pankowska, Ewa, Mazurczak, Karolina · 2018 · Journal of Diabetes
  77. Relationships Between the Cumulative Incidences of Long-term Complications in Type 1 Diabetes: The DCCT/EDIC Study
    Ionut Bebu, Barbara H. Braffett, Ian H. de Boer, Lloyd Paul Aiello, John P. Bantle, Gayle M. Lorenzi, William H. Herman, Rose Gubitosi‐Klug, Bruce A. Perkins, John M. Lachin et al. · 2022 · Diabetes Care
  78. ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE
    Adrian Liew, Sunita Bavanandan, Narayan Prasad, Muh Geot Wong, Jer Ming Chang, Somchai Eiam‐Ong, Chuan‐Ming Hao, Chiao Yuen Lim, Soo Kun Lim, Kook‐Hwan Oh et al. · 2020 · Nephrology
  79. Pancreatic islet reserve in type 1 diabetes
    Anneliese J. Flatt, Carla J. Greenbaum, James Shaw, Michael Roehrhoff Rickels · 2021 · Annals of the New York Academy of Sciences
  80. Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?
    Theano Penlioglou, Anca Pantea Stoian, Νικόλαος Παπάνας · 2021 · Journal of Clinical Medicine
  81. Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study
    Kirsten Nørgaard, Ajenthen Gayathri Ranjan, Christian Laugesen, Katrine G Tidemand, Allan Green, Christian Selmer, Jannet Svensson, Henrik Ullits Andersen, Dorte Vistisen, Bendix Carstensen · 2023 · Diabetes Care
  82. Electrocardiographic Abnormalities and Cardiovascular Disease Risk in Type 1 Diabetes: The Epidemiology of Diabetes Interventions and Complications (EDIC) Study
    Elsayed Z. Soliman, Jye‐Yu C. Backlund, Ionut Bebu, Trevor John Orchard, Bernard Zinman, John M. Lachin · 2017 · Diabetes Care
  83. Optimal blood pressure thresholds for minimal coronary artery disease risk in type 1 diabetes
    Guo, Jingchuan, Brooks, Maria M., Muldoon, Matthew F., Naimi, Ashely I., Orchard, Trevor J., Costacou, Tina · 2019 · Diabetes Care
  84. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus
    Hemmingsen, Bianca, Metzendorf, Maria-Inti, Richter, Bernd · 2021 · Cochrane Database of Systematic Reviews
  85. Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy
    Amit K. Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati · 2021 · Frontiers in Physiology
  86. The role of hydrogen in the prevention and treatment of coronary atherosclerotic heart disease
    Yunxi Chen, Youzhen Wei, Wenjie Tang · 2024 · European Journal of Pharmacology
  87. Closed-loop insulin delivery: current status of diabetes technologies and future prospects
    Waseem Majeed, Hood Thabit · 2018 · Expert Review of Medical Devices
  88. Targets for blood glucose: What have the trials told us
    Paul Elie Valensi, Gaëtan Prévost, Oliver Schnell, Eberhard Standl, Antonio Ceriello · 2019 · European Journal of Preventive Cardiology
  89. Personalized insulin dosing using reinforcement learning for high-fat meals and aerobic exercises in type 1 diabetes: a proof-of-concept trial
    Adnan Jafar, Alessandra Kobayati, Michael A. Tsoukas, Ahmad Haidar · 2024 · Nature Communications
  90. Glycemic Management Across the Lifespan for People With Type 1 Diabetes: A Clinical Practice Guideline
    Halperin, Ilana J., Wicklow, Brandy, Amed, Shazhan, Chambers, Alanna, Courage, Charlotte, Cummings, Elizabeth, Kirkland, Patricia, MacKay, Dylan, Nakhla, Meranda, Punthakee, Zubin et al. · 2025 · Canadian Journal of Diabetes
  91. Anti-CD3 monoclonal antibodies for the prevention and treatment of type 1 diabetes: A literature review
    James LeFevre, Sneha L Cyriac, Adna Tokmic, Jamie M. Pitlick · 2022 · American Journal of Health-System Pharmacy
  92. Interrupting prolonged sitting with frequent short bouts of light‐intensity activity in people with type 1 diabetes improves glycaemic control without increasing hypoglycaemia: The SIT‐LESS randomised controlled trial
    Matthew D. Campbell, Anwar M. Alobaid, Mark Hopkins, Paddy C. Dempsey, Sam Matthew Pearson, Noppadol Kietsiriroje, Rachel Churm, Ramzi Ajjan · 2023 · Diabetes Obesity and Metabolism
  93. Xanthine oxidoreductase activity correlates with vascular endothelial dysfunction in patients with type 1 diabetes
    Kahori Washio, Yoshiki Kusunoki, Taku Tsunoda, Keiko Osugi, Mana Ohigashi, Takayo Murase, Takashi Nakamura, Toshihiro Matsuo, Kosuke Konishi, Tomoyuki Katsuno et al. · 2019 · Acta Diabetologica
  94. Bone marrow mesenchymal stem cell and mononuclear cell combination therapy in patients with type 2 diabetes mellitus: a randomized controlled study with 8-year follow-up
    Zhixian Wu, Shulin Huang, Shasha Li, Jinquan Cai, Lianghu Huang, Weizhen Wu, Jin Chen, Jianming Tan · 2024 · Stem Cell Research & Therapy
  95. Undiagnosed coronary artery disease in long-term type 1 diabetes. The Dialong study
    Kristine Bech Holte, Mona Svanteson, Kristian Folkvord Hanssen, Ylva Haig, Svein Solheim, Tore Julsrud Berg · 2019 · Journal of Diabetes and its Complications
  96. Primary Care Providers in California and Florida Report Low Confidence in Providing Type 1 Diabetes Care
    Rayhan Lal, Nicolas Cuttriss, Michael J. Haller, Katarina Yabut, CLAUDIA ANEZ-ZABALA, Korey K. Hood, Eleni Sheehan, Marina Basina, Angelina Valladares Bernier, LINDA G. BAER et al. · 2020 · Clinical Diabetes
  97. Full closed loop open‐source algorithm performance comparison in pigs with diabetes
    Rayhan Lal, Caitlin L. Maikawa, Dana Michelle Lewis, Sam W. Baker, Anton A. A. Autzen, Gillie A. Roth, Emily C. Gale, Lyndsay M. Stapleton, Joseph L. Mann, Anthony C. Yu et al. · 2021 · Clinical and Translational Medicine
  98. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus
    Carlo Di Mario, Stefano Genovese, Gaetano Antonio Lanza, Edoardo Mannucci, Giancarlo Marenzi, Edoardo Sciatti, Dario Pitocco, the Expert Panel Group, Angelo Avogaro, Federico Bertuzzi et al. · 2022 · Cardiovascular Diabetology
  99. Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial
    Emilie Bundgaard Lindkvist, Christian Laugesen, Asbjørn Thode Reenberg, Tobias Kasper Skov Ritschel, Jannet Svensson, John Bagterp Jørgensen, Kirsten Nørgaard, Ajenthen Gayathri Ranjan · 2023 · Frontiers in Endocrinology
  100. A Decade of Pancreas Transplantation—A Registry Report
    Angelika C. Gruessner · 2023 · Uro